May 07, 2018

New blood test can instantly diagnose pain using colour

For some patients, such as those with advanced dementia or the very frail and ill, it can be difficult to know if they are suffering pain because they are not able to communicate it.

But that might be about to change, with a new blood test being developed by Australian scientists that will allow medical professionals to provide an instant diagnosis of pain.

One in five Australians are said to suffer chronic pain.

The scientists developed the tool after they discovered that different types of pain have different colour biomarkers.

In particular, immune cells are a different colour for those in acute pain.

A light measurement tool – called hyerspectral imaging analysis – is used to examine the blood and will enable medical staff to instantly determine if the patient is in acute pain.

“We are literally quantifying the colour of pain,” said Professor Mark Hutchinson.

“We’ve now discovered that we can use the natural colour of biology to predict the severity of pain. What we’ve found is that persistent chronic pain has a different natural colour in immune cells than in a situation where there isn’t persistent pain.”

“We will be able to take a simple blood sample, and within minutes we are able to determine if someone has persistent pain.”

The test is expected to be helpful for patients who aren’t able to communicate, such as patients with advanced dementia, babies and children, and even animals.

But Professor Huchinson said the test should not be seen as a replacement for patients talking to their doctor about their pain.

The ‘forgotten people’ who aren’t able to communicate their pain

“What this does mean is that those ‘forgotten people’ who are unable to communicate their pain conditions such as babies or people with dementia can now have their condition diagnosed and treated,” he said.

It is hoped that the test, which is called painHS, will be available for use within 18 months.

The new test was revealed at the Faculty of Pain Medicine (FPM) conference in Sydney on the weekend.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

“What would happen if I was unconscious or can’t talk?”: meet the smartwatch that calls for help after a fall

"what would happen if I was unconscious or couldn't talk - how would I tell someone that I needed emergency help? That's why I have the MePACS Solo now, because it has automatic falls detection and can alert MePACS for me." Read More

Drug Which Prevents Fractures in People with Osteoporosis Approved For Use in UK

A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of fractures. Read More

How this technology solution has increased the quality of home care

There was a moment in the height of the pandemic when it was clear Regal Home Health’s new technology system had improved more than its rostering efficiency – it was driving outstanding customer service. Read More
Advertisement